News | Dermatology

News

Medicines regulator issues advice to prevent severe harm from JAK inhibitors

The Medicines and Healthcare products Regulatory Agency has advised against prescribing janus kinase inhibitors in patients with certain risk factors.…

Published: 28 April 2023

News

Two prescribers must agree that acne is ‘severe enough’ before under-18s are prescribed isotretinoin, review concludes

The Commission on Human Medicines' recommendations will be taken forward by the Medicines and Healthcare products Regulatory Agency to support the acne drug's safe use.…

Published: 26 April 2023

News

Pharmacists should be able to refer patients directly to secondary care for skin conditions, says APPG chair

Exclusive: Taiwo Owatemi, chair of the All-Party Pharmacy Group, has said pharmacists could "easily" help with dermatology referrals.…

Published: 20 February 2023

Opinion

Closing the MPharm awarding gap

It is vital that we work to reduce the awarding gap between white students and black, Asian and minority ethnic students — the race equity programme at the University of Sussex is an example of what can be achieved through collaboration between students and staff.…

Published: 10 October 2022

Feature

‘We are trained to work safely and within certain parameters’

Dianne Sanderson, senior clinical pharmacist and dermatology pharmacist, Vernova Healthcare, Cheshire…

Published: 6 October 2022

News

More than half of pharmacists have been asked about medicines that patients had seen on social media, finds survey

Exclusive: In a survey of nearly 1,600 pharmacists, 910 said a patient had asked them about medicines or products they had seen on social media.…

Published: 21 September 2022

News

Biologic shown to reduce eczema symptoms in young children by three quarters

More than half of the children in the study had at least a 75% reduction in signs of eczema, as well as reductions in itch and improved sleeping patterns.…

Published: 16 September 2022

News

Topical corticosteroids to come with warning about withdrawal effects following MHRA review

The Medicines and Healthcare products Regulatory Agency says withdrawal symptoms from topical corticosteroids include skin redness, burning and/or itchiness, which may be followed by skin peeling.…

Published: 17 September 2021

Feature

Managing childhood eczema: a visual guide

Research has revealed concerns about using topical corticosteroids in children with eczema, both among parents and pharmacists, leading to suboptimal treatment that perpetuates the condition.…

Published: 19 August 2021

Supported content

News

Addition of baricitinib to mainstay of treatment improves signs and symptoms of atopic dermatitis, study finds

Adding the oral selective Janus kinase 1 and 2 inhibitor, baricitinib, to topical corticosteroid treatment significantly improves the signs and symptoms of moderate-to-severe atopic dermatitis, a phase III study in JAMA Dermatology has suggested.…

Published: 15 October 2020